09:46 AM EST, 11/11/2025 (MT Newswires) -- Novo Nordisk ( NVO ) has reduced the price of its weight management drug Wegovy by up to 33% in India, Reuters reported Tuesday, citing a document sent by the company to distributors.

The price cut comes days after Eli Lilly's ( LLY ) Mounjaro became India's top-selling drug by value in October, according to the report. Mounjaro, which is approved for managing type 2 diabetes, also contains tirzepatide, the active ingredient in Lilly's weight loss drug Zepbound.

Novo Nordisk ( NVO ) did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 47.33, Change: +1.38, Percent Change: +3.00